Immunome, Inc. (IMNM) Operating income 2019–2025
Immunome, Inc. (IMNM) annual operating income history from SEC filings — each fiscal year as reported.
-$224.1MFY2025 · since FY2019: -$10.3M → -$224.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$224.1M | +26.7% |
| FY2024 | -$305.8M | -179.2% |
| FY2023 | -$109.5M | -196.8% |
| FY2022 | -$36.9M | -46.4% |
| FY2021 | -$25.2M | -105.6% |
| FY2020 | -$12.3M | -18.5% |
| FY2019 | -$10.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice